Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed multiple myeloma

Regional radiation benefits high risk breast cancer patients

Axillary dissection in clinically node negative breast cancer patients undergoing breast conserving surgery

Practical approach to the management of the axilla after neoadjuvant chemotherapy

Modern methods of phase 1 clinical trial design

Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from the phase III SOLAR-1 trial

Polygenic risk scores for breast cancer: ready or not?

Modulation of anti-tumour immunity using CDK4/6 inhibitors

Brain metastases developed from HER2 positive and triple negative breast cancer

Single cell genomics in breast cancer: breast tumour evolution and intra-tumour heterogeneity

Chemo-immuno combination shows improved PFS when compared with sole chemotherapy treatment in advanced breast cancer

Association of pathologic complete response following neoadjuvant chemotherapy with longterm survival in breast cancer